Sign in

CIK 0001393434

  • Large accelerated filer

OCULAR THERAPEUTIX, INC

Sign in to watch
Ticker
OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-357-4000
Business address
14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
Former names
I-THERAPEUTIX INC
  1. 4 Planned sale Chief Scientific Officer sold 3,061 shares at $6.87 ($21,029)
  2. 4 Planned sale Chief Development Officer sold 3,009 shares at $6.87 ($20,672)
  3. 4 Planned sale Chief Strategy Officer sold 1,895 shares at $6.84 ($12,962)
  4. 4 Grant or award Dugel Pravin acquired 2,750,000 shares (grant or award)
  5. 4 Grant or award Chief Medical Officer acquired 79,000 shares (grant or award)
  6. 4 Grant or award Notman Donald acquired 115,000 shares (grant or award)
  7. 4 Grant or award Chief Strategy Officer acquired 111,000 shares (grant or award)
  8. 4 Open-market sale Notman Donald sold 17,420 shares at an average $7.82 ($136,239)
  9. 4 Planned sale Chief Scientific Officer sold 2,948 shares at $9.01 ($26,561)
  10. 4 Planned sale Chief Development Officer sold 2,897 shares at $9.01 ($26,102)
  11. 4 Planned sale Chief Strategy Officer sold 1,814 shares at $9.00 ($16,326)
  12. 4 Planned sale Dugel Pravin sold 20,680 shares at $9.01 ($186,327)
  13. 4 Grant or award Chief Legal Officer acquired 98,700 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award Chief Development Officer acquired 100,000 shares (grant or award)
  16. 4 Grant or award Chief Scientific Officer acquired 100,000 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4 Grant or award Notman Donald acquired 11,034 shares (grant or award)
  20. 4 Planned sale Chief Strategy Officer sold 1,832 shares at $9.02 ($16,525)

Page 5 of 18 · 354 filings